Munich, Germany

Axel Wunderlich

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Raumedic Ag. Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Axel Wunderlich: Innovator in Fluid Connection Technology

Introduction

Axel Wunderlich is a notable inventor based in Munich, Germany. He has made significant contributions to the field of fluid connection technology, particularly through his innovative patent. His work focuses on creating secure and efficient connections between silicone hose components.

Latest Patents

Wunderlich holds a patent for a process that manufactures an impermeable connection between at least two fluid-carrying silicone hose components and a silicone connector component. The patent describes a method where silicone hose components and a connector are prepared, followed by the application of a fluid silicone mass to the connecting areas. This process ensures that the connection is not only secure but also allows for automation in manufacturing fluid-carrying assemblies.

Career Highlights

Wunderlich is associated with Raumedic AG, a company known for its expertise in medical technology and fluid management solutions. His work has contributed to advancements in the manufacturing processes used in the industry.

Collaborations

Throughout his career, Axel Wunderlich has collaborated with notable colleagues, including Jörg Prescher and Robert Reichenberger. These partnerships have fostered innovation and development in their respective fields.

Conclusion

Axel Wunderlich's contributions to fluid connection technology exemplify the importance of innovation in manufacturing processes. His patent reflects a commitment to enhancing the efficiency and security of fluid-carrying assemblies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…